Molecular Ensembles of Microbiotic Metabolites in Carcinogenesis
-
Published:2023-07
Issue:7
Volume:88
Page:867-879
-
ISSN:0006-2979
-
Container-title:Biochemistry (Moscow)
-
language:en
-
Short-container-title:Biochemistry Moscow
Author:
Shatova Olga P.,Zabolotneva Anastasiya A.,Shestopalov Aleksandr V.
Abstract
Abstract
The mechanisms of carcinogenesis are extremely complex and involve multiple components that contribute to the malignant cell transformation, tumor growth, and metastasis. In recent decades, there has been a growing interest in the role of symbiotic human microbiota in the regulation of metabolism and functioning of host immune system. The symbiosis between a macroorganism and its microbiota has given rise to the concept of a holoorganism. Interactions between the components of a holoorganism have formed in the process of coevolution, resulting in the acquisition by microbiotic metabolites of a special role of signaling molecules and main regulators of molecular interactions in the holoorganism. As elements of signaling pathways in the host organism, bacterial metabolites have become essential participants in various physiological and pathological processes, including tumor growth. At the same time, signaling metabolites often exhibit multiple effects and impact both the functions of the host cells and metabolic activity and composition of the microbiome. This review discusses the role of microbiotic metabolites in the induction and prevention of malignant transformation of cells in the host organism and their impact on the efficacy of anticancer therapy, with special emphasis on the involvement of some components of the microbial metabolite molecular ensemble in the initiation and progression of tumor growth.
Publisher
Pleiades Publishing Ltd
Subject
Biochemistry,General Medicine,Biochemistry, Genetics and Molecular Biology (miscellaneous),Biophysics,Geriatrics and Gerontology
Reference91 articles.
1. Popova, O. P., Shegay, P. V., Ivanov, A. A., Danilova, T. I., Alekseev, B. Ya., and Kaprin, A. D. (2008) Molecular mechanisms in developing prostate cancer: a correlation between EGF, HGF and VEGF levels as well as clinical and morphological parameters [in Russian], Mol. Med., 4, 40-46. 2. Zolotovskaia, M. A., Sorokin, M. I., Petrov, I. V., Poddubskaya, E. V., Moiseev, A. A., Sekacheva, M. I., Borisov, N. M., Tkachev, V. S., Garazha, A. V., Kaprin, A. D., Shegay, P. V., Giese, A., Kim, E., Roumiantsev, S. A., and Buzdin, A. A. (2020) Disparity between inter-patient molecular heterogeneity and repertoires of target drugs used for different types of cancer in clinical oncology, Int. J. Mol. Sci., 21, 1580, doi: 10.3390/ijms21051580. 3. Dominguez-Bello, M. G., Godoy-Vitorino, F., Knight, R., and Blaser, M. J. (2019) Role of the microbiome in human development, Gut, 68, 1108-1114,
https://doi.org/10.1136/gutjnl-2018-317503. 4. Agus, A., Clément, K., and Sokol, H. (2021) Gut microbiota-derived metabolites as central regulators in metabolic disorders, Gut, 70, 1174-1182,
https://doi.org/10.1136/gutjnl-2020-323071. 5. Matson, V., Chervin, C. S., and Gajewski, T. F. (2021) Cancer and the microbiome – influence of the commensal microbiota on cancer, immune responses, and immunotherapy, Gastroenterology, 160, 600-613,
https://doi.org/10.1053/j.gastro.2020.11.041.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|